Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LIFE | FATE | SPRO | ||
| Company | Atyr Pharma Inc | Fate Therapeutics | Spero Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.8600 | 1.1200 | 2.36 | ||
| High | 1.9500 | 1.1650 | 2.36 | ||
| Low | 1.8200 | 1.0900 | 2.30 | ||
| Latest | 1.9000 | 1.1500 | 2.32 | ||
| Change | +0.0500 | +0.0400 | -0.03 | ||
| % Change | +2.70% | +3.60% | -1.28% | ||
| Volume | 269,400 | 1,407,600 | 287,700 | ||
| 20-Day Average Volume | 540,290 | 1,219,535 | 343,190 | ||
| Previous Close | 1.8500 | 1.1100 | 2.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.8177 | 1.0591 | 2.33 | ||
| 20-Day Raw Stochastic | 58.70% | 93.02% | 35.90% | ||
| 20-Day Relative Strength | 56.18 | 51.11 | 50.12 | ||
| Weighted Alpha | -6.86 | -50.44 | -19.28 | ||
| Today's Opinion | 100% Buy | 8% Sell | 40% Buy | ||
| Previous Opinion | 96% Buy | 24% Sell | 88% Buy | ||
| Last Month's Opinion | 8% Buy | 8% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.15% since 05/28/24 | +6.48% since 12/05/25 | +2.65% since 12/05/25 | ||
| Low | 1.6500 on 05/30/24 | 1.0300 on 12/08/25 | 2.26 on 12/09/25 | ||
| High | 1.9500 on 06/04/24 | 1.1650 on 12/12/25 | 2.39 on 12/10/25 | ||
| 1-Month | |||||
| %Chg | +18.01% since 05/03/24 | +10.58% since 11/12/25 | -12.78% since 11/12/25 | ||
| Low | 1.5901 on 05/06/24 | 0.9500 on 11/14/25 | 2.18 on 12/03/25 | ||
| High | 2.0900 on 05/21/24 | 1.1650 on 12/12/25 | 2.72 on 11/13/25 | ||
| 3-Month | |||||
| %Chg | +6.15% since 03/04/24 | +19.41% since 09/12/25 | +22.11% since 09/12/25 | ||
| Low | 1.5400 on 05/02/24 | 0.9401 on 09/15/25 | 1.84 on 09/30/25 | ||
| High | 2.1500 on 03/20/24 | 1.9399 on 10/27/25 | 2.75 on 11/12/25 | ||
| 6-Month | |||||
| %Chg | +50.20% since 12/04/23 | -17.86% since 06/12/25 | -19.72% since 06/12/25 | ||
| Low | 1.1400 on 12/11/23 | 0.9100 on 08/11/25 | 1.80 on 08/20/25 | ||
| High | 2.1500 on 03/20/24 | 1.9399 on 10/27/25 | 3.22 on 07/09/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 131,121 | 132,655 | 130,706 | ||
| Shares Outstanding, K | 69,011 | 115,352 | 56,339 | ||
| Annual Sales | 350,000 | 13,630,000 | 47,980,000 | ||
| Annual Net Income | -50,390,000 | -186,260,000 | -68,570,000 | ||
| Last Quarter Sales | 240,000 | 1,740,000 | 5,440,000 | ||
| Last Quarter Net Income | -15,490,000 | -32,250,000 | -7,380,000 | ||
| 60-Month Beta | 1.19 | 2.34 | 1.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 05/02/24 | -0.27 on 11/13/25 | -0.13 on 11/13/25 | ||
| Latest Earnings Date | 08/14/24 | 03/04/26 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 09/16/15 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||